Alkermes
ALKS
#2942
Rank
A$8.03 B
Marketcap
A$48.67
Share price
-2.84%
Change (1 day)
-5.17%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: A$8.03 Billion

As of February 2026 Alkermes has a market cap of A$8.03 Billion. This makes Alkermes the world's 2942th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$8.03 B14.41%
2025A$7.02 B-8.63%
2024A$7.68 B13.13%
2023A$6.79 B7.7%
2022A$6.30 B21.61%
2021A$5.18 B25.65%
2020A$4.12 B-10.18%
2019A$4.59 B-29.54%
2018A$6.52 B-39.48%
2017A$10.78 B-8%
2016A$11.71 B-28.64%
2015A$16.42 B55.55%
2014A$10.55 B68.08%
2013A$6.28 B166.16%
2012A$2.35 B7.56%
2011A$2.19 B90.37%
2010A$1.15 B16.52%
2009A$0.98 B-31.15%
2008A$1.43 B-19.72%
2007A$1.78 B4.5%
2006A$1.71 B-28.48%
2005A$2.39 B45.57%
2004A$1.64 B1.66%
2003A$1.61 B124.1%
2002A$0.72 B-78.3%
2001A$3.32 B3.52%
2000A$3.21 B68.38%
1999A$1.90 B148.74%
1998A$0.76 B20.49%
1997A$0.63 B17.48%
1996A$0.54 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Alkermes was reported to be:

A$8.03 Billion
by Nasdaq info icon info icon
A$8.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$786.22 B 9,684.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$409.67 B 4,998.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$215.87 B 2,586.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$164.07 B 1,941.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$160.92 B 1,902.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$413.05 B 5,040.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
A$2.15 B-73.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$56.14 B 598.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel